Paget's disease of the nipple: A copy number of the genes ERBB2 and CCND1 versus expression of the proteins ERBB-2 and cyclin D1

Neoplasma

Volumn 50, Issue 6, 2003, Pages 396-402

  Mrhalova, M ^a   Kodet, R ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

CCND1; ERBB2; Fluorescence in situ hybridization; Immunohistochemistry; Interphasic nuclei; Paget's disease of the nipple

Indexed keywords

CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FORMALDEHYDE; PARAFFIN; SIGNAL PEPTIDE; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CANCER CELL; CANCER IMMUNOTHERAPY; CANCER INVASION; CARCINOMA IN SITU; CCND1 GENE; CELL PROLIFERATION; CHROMOSOME 11; CHROMOSOME 17; CLINICAL ARTICLE; EPIDERMIS; ERBB2 GENE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENE COPY; GENE DUPLICATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERPHASE; INTERPHASIC NUCLEI; INVASIVE CARCINOMA; INVASIVE DUCTAL CARCINOMA; KERATINOCYTE; PAGET CELL; PAGET NIPPLE DISEASE; PROTEIN EXPRESSION; STAINING; TISSUE SECTION; TUMOR BIOPSY; TUMOR CELL;

EID: 0348148826     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. BARBARESCHI M, PELOSIO P, CAFFO O, BUTTITTA F, PELLEGRINI S, BARBAZZA R, DALLA PALMA P, BEVILACQUA G, MARCHETTI A. Cyclin-D1-gene amplification and expression in breast carcinoma: relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21WAF1 immunohistochemical expression. Int J Cancer 1997; 74: 171-174.
2. BARNES DM, GILLETT CE. Cyclin D1 in breast cancer. Breast Cancer Res Treat 1998; 52: 1-15.
3. BIJKER N, RUTGERS EJ, DUCHATEAU L, PETERSE JL, JULIEN JP, CATALIOTTI L. Breast-conserving therapy for Paget disease of the nipple: a prospective European Organization for Research and Treatment of Cancer study of 61 patients. Cancer 2001; 91: 472-477.
4. BUKHOLM IK, BERNER JM, NESLAND JM, BORRESEN-DALE AL. Expression of cyclin Ds in relation to p53 status in human breast carcinomas. Virchows Arch 1998; 433: 223-228.
5. COUTURIER J, VINCENT-SALOMON A, NICOLAS A, BEUZEBOC P, MOURET E, ZAFRANI B, SASTRE-GARAU X. Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma. Mod Pathol 2000; 13: 1238-1243.
6. DE POTTER CR, EECKHOUT I, SCHELFHOUT AM, GEERTS ML, ROELS HJ. Keratinocyte induced chemotaxis in the pathogenesis of Paget's disease of the breast. Histopathology 1994; 24: 349-356.
7. FOSTER JS, HENLEY DC, AHAMED S, WIMALASENA J. Estrogens and cell-cycle regulation in breast cancer. Trends Endocrinol Metab 2001; 12: 320-327.
8. FRIERSON HF JR., GAFFEY MJ, ZUKERBERG LR, ARNOLD A, WILLIAMS ME. Immunohistochemical detection and gene amplification of cyclin D1 in mammary infiltrating ductal carcinoma. Mod Pathol 1996; 9: 725-730.
9. HUNG MC, LAU YK. Basic science of HER-2/neu: a review. Semin Oncol 1999; 26: 51-59.
10. HYNES NE, STERN DF. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta 1994; 1198: 165-184.
11. IGLEHART JD, KRAUS MH, LANGTON BC, HUPER G, KERNS BJ, MARKS JR. Increased erbB-2 gene copies and expression in multiple stages of breast cancer. Cancer Res 1990; 50: 6701-6707.
12. INABA T, MATSUSHIME H, VALENTINE M, ROUSSEL MF, SHERR CJ, LOOK AT. Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. Genomics 1992; 13: 565-574.
13. KOEPPEN HK, WRIGHT BD, BURT AD, QUIRKE P, McNICOL AM, DYBDAL NO, SLIWKOWSKI MX, HILLAN KJ. Overexpression of HER2/neu in solid tumours: an immunohistochemical survey. Histopathology 2001; 38: 96-104.
14. KOTHARI AS, BEECHEY-NEWMAN N, HAMED H, FENTIMAN IS, D'ARRIGO C, HANBY AM, RYDER K. Paget disease of the nipple: a multifocal manifestation of higher-risk disease. Cancer 2002; 95: 1-7.
15. LLOYD J, FLANAGAN AM. Mammary and extramammary Paget's disease. J Clin Pathol 2000; 53: 742-749.
16. MEISSNER K, RIVIERE A, HAUPT G, LONING T. Study of neuprotein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease. Am J Pathol 1990; 137: 1305-1309.
17. MRHALOVA M, KODET R, STRNAD P. Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection. Cas Lek Ces 2002; 141: 708-714.
18. MRHALOVA M, KODET R, STRNAD P. Correlation of c-erbB-2 gene expression (detected by FISH) with membrane expression of erbB-2 protein (detected by IHC) in patients with primary breast carcinomas. Cas Lek Ces 2001; 140: 553-559.
19. MUHLMANN M. Molecular cytogenetics in metaphase and interphase cells for cancer and genetic research, diagnosis and prognosis. Application in tissue sections and cell suspensions. Genet Mol Res 2002; 1: 117-127.
20. MULERIS M, ALMEIDA A, MALFOY B, DUTRILLAUX B. Assignment of v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (ERBB2) to human chromosome band 17q21.1 by in situ hybridization. Cytogenet Cell Genet 1997; 76: 34-35.
21. NEUMAN E, LADHA MH, LIN N, UPTON TM, MILLER SJ, DIRENZO J, PESTELL RG, HINDS PW, DOWDY SF, BROWN M, EWEN ME. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol 1997; 17: 5338-5347.
22. NIEHANS GA, SINGLETON TP, DYKOSKI D, KIANG DT. Stability of HER-2/neu expression over time and at multiple metastatic sites. J Natl Cancer Inst 1993; 85: 1230-1235.
23. POLGAR C, OROSZ Z, KOVACS T, FODOR J. Breast-conserving therapy for Paget disease of the nipple: a prospective European Organization for Research and Treatment of Cancer study of 61 patients. Cancer 2002; 94: 1904-1905.
24. SAKORAFAS GH, BLANCHARD K, SARR MG, FARLEY DR. Paget's disease of the breast. Cancer Treat Rev 2001; 27: 9-18.
25. SAUTER G, FEICHTER G, TORHORST J, MOCH H, NOVOTNA H, WAGNER U, DURMULLER U, WALDMAN FM. Fluorescence in situ hybridization for detecting erbB-2 amplification in breast tumor fine needle aspiration biopsies. Acta Cytol 1996; 40: 164-173.
26. SCHELFHOUT VR, COENE ED, DELAEY B, THYS S, PAGE DL, DE POTTER CR. Pathogenesis of Paget's disease: epidermal heregulin-alpha, motility factor, and the HER receptor family. J Natl Cancer Inst 2000; 92: 622-628.
27. SIMPSON JF, QUAN DE, O'MALLEY F, ODOM-MARYON T, CLARKE PE. Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast. Am J Pathol 1997; 151: 161-168.
28. SLAMON DJ, CLARK GM, WONG SG, LEVIN WJ, ULLRICH A, McGUIRE WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177-182.
29. SLAMON DJ, GODOLPHIN W, JONES LA, HOLT JA, WONG SG, KEITH DE, LEVIN WJ, STUART SG, UDOVE J, ULLRICH A, PRESS MF. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989; 244: 707-712.
30. SUTHERLAND RL, HAMILTON JA, SWEENEY KJ, WATTS CK, MUSGROVE EA. Expression and regulation of cyclin genes in breast cancer. Acta Oncol 1995; 34: 651-656.
31. WOLBER RA, DUPUIS BA, WICK MR. Expression of c-erbB-2 oncoprotein in mammary and extramammary Paget's disease. Am J Clin Pathol 1991; 96: 243-247.
32. YOKOTA J, YAMAMOTO T, TOYOSHIMA K, TERADA M, SUGIMURA T, BATTIFORA H, CLINE MJ. Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet 1986; 1: 765-767.
33. ZHOU D, BATTIFORA H, YOKOTA J, YAMAMOTO T, CLINE MJ. Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer. Cancer Res 1987; 47: 6123-6125.